HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Pituitary Tumors

Pituitary Tumors

Pituitary tumors, though typically benign, can cause significant health issues by disrupting hormone production. Research in this field focuses on understanding the genetic and molecular mechanisms driving tumor formation and growth. Scientists explore targeted therapies to shrink tumors without harming healthy tissue, aiming to improve patient outcomes and quality of life. Advanced imaging techniques aid in early detection and precise tumor localization, guiding treatment strategies. Additionally, investigations into hormone replacement therapies help manage the hormonal imbalances resulting from pituitary dysfunction. Collaborative efforts among clinicians, researchers, and patients are crucial for advancing treatment options and enhancing our understanding of pituitary tumor biology. By unraveling the complexities of these tumors, researchers strive to develop personalized approaches tailored to each patient's unique needs, ultimately offering hope for better prognosis and improved survival rates.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp